abstract |
The invention relates to new pharmaceutically useful compounds of formula (I), in particular to compounds that are competitive inhibitors of trypsin-like serine proteases, in particular thrombin, their use as pharmaceuticals, pharmaceutical compositions and synthetic routes for their preparation. |